Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

Erik S. Musiek; John C. Morris

doi:10.1001/jamaneurol.2020.4478

Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	141-142
Number of pages	2
Journal	JAMA Neurology
Volume	78
Issue number	2
DOIs	https://doi.org/10.1001/jamaneurol.2020.4478
State	Published - Feb 2021

Access to Document

10.1001/jamaneurol.2020.4478

Cite this

@article{d796c817dbcd4375af40db453f47d91b,

title = "Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease",

author = "Musiek, {Erik S.} and Morris, {John C.}",

note = "Funding Information: grants from Eisai Pharmaceuticals, the National Institutes of Health, and Cure Alzheimer{\textquoteright}s Fund outside of this work and consulting for Eisai Pharmaceuticals. Dr Morris is funded by the National Institutes of Health (grants P30 AG066444, P01AG003991, P01AG026276, U19 AG032438, and U19 AG024904).",

year = "2021",

month = feb,

doi = "10.1001/jamaneurol.2020.4478",

language = "English",

volume = "78",

pages = "141--142",

journal = "JAMA Neurology",

issn = "2168-6149",

number = "2",

}

TY - JOUR

T1 - Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

AU - Musiek, Erik S.

AU - Morris, John C.

N1 - Funding Information: grants from Eisai Pharmaceuticals, the National Institutes of Health, and Cure Alzheimer’s Fund outside of this work and consulting for Eisai Pharmaceuticals. Dr Morris is funded by the National Institutes of Health (grants P30 AG066444, P01AG003991, P01AG026276, U19 AG032438, and U19 AG024904).

PY - 2021/2

Y1 - 2021/2

UR - http://www.scopus.com/inward/record.url?scp=85097496009&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2020.4478

DO - 10.1001/jamaneurol.2020.4478

M3 - Comment/debate

C2 - 33252672

AN - SCOPUS:85097496009

SN - 2168-6149

VL - 78

SP - 141

EP - 142

JO - JAMA Neurology

JF - JAMA Neurology

IS - 2

ER -

Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

Access to Document

Other files and links

Cite this